ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,949.17
-0.60%
US Tech 100
20,215.20
-0.65%
Dow Jones
43,750.86
-0.47%
Brent Oil
72.10
-0.15%
Bitcoin
90,283.59
3.37%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Sutro Biopharma Inc (STRO) Quote

Sutro Biopharma Inc

Sutro Biopharma Inc (STRO)

NASDAQ
3.45
-0.51
(-12.88%)
Closed November 14 4:00PM
Delayed by 15 minutes
3.45
0.00
( 0.00% )
Pre Market: 7:00AM
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
3.45
Bid
3.42
Ask
3.45
Volume
6
0.00 Day's Range 0.00
2.13 52 Week Range 6.13
Market Cap
282.775M
Previous Close
3.45
Open
-
Last Trade
6
@
3.45
Last Trade Time
07:00:21
Financial Volume
-
VWAP
-
Average Volume (3m)
567,164
Shares Outstanding
81,963,659
Dividend Yield
-
PE Ratio
-2.65
Earnings Per Share (EPS)
-1.3
Revenue
153.73M
Net Profit
-106.79M

About Sutro Biopharma Inc

Sutro Biopharma Inc is clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated ce... Sutro Biopharma Inc is clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
www.sutrobio.com
Headquarters
South San Francisco, California, USA
Founded
-
Sutro Biopharma Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker STRO. The last closing price for Sutro Biopharma was $3.45. Over the last year, Sutro Biopharma shares have traded in a share price range of $ 2.13 to $ 6.13.

Sutro Biopharma currently has 81,963,659 shares outstanding. The market capitalization of Sutro Biopharma is $282.77 million. Sutro Biopharma has a price to earnings ratio (PE ratio) of -2.65.

Ask ADVFN Intelligence (AI)

STRO Latest News

More News

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

12 hours ago
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

November 13 2024
Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

November 13 2024
Edgar (US Regulatory)

Sutro Biopharma Reports Third Quarter 2024 Financial Results and Business Highlights

- Expects to deliver three Investigational New Drug (IND) applications in next three years based on next-generation ADC technology - - Two new clinical trials, REFRαME-P1, a registration-enabling...

November 13 2024
GlobeNewswire Inc.

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

November 12 2024
Edgar (US Regulatory)

Sutro Biopharma Demonstrates Meaningful ADC Innovation with Five Presentations at the 15th Annual World ADC Conference

SOUTH SAN FRANCISCO, Calif., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and...

November 04 2024
GlobeNewswire Inc.

Sutro Biopharma Announces Initiation of the Registration-enabling REFRαME-P1 Trial with Luvelta for Pediatric Patients with CBF/GLIS AML

SOUTH SAN FRANCISCO, Calif., Nov. 01, 2024 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and...

November 01 2024
GlobeNewswire Inc.

Sutro Biopharma Highlights Next-Generation ADC Innovation and Near-term Pipeline at Research Forum

Proprietary cell-free platform enables the design of next-generation ADCs intended to broaden addressable patient populations STRO-004 (tissue factor ADC) preclinical data has demonstrated...

October 10 2024
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

September 20 2024
Edgar (US Regulatory)

Sutro Biopharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

SOUTH SAN FRANCISCO, Calif., Sept. 20, 2024 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and...

September 20 2024
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.67-16.26213592234.124.63.425247364.05650387CS
4-0.27-7.258064516133.724.63.225236463.76999318CS
12-1.18-25.48596112314.635.173.225671643.89858669CS
26-0.89-20.50691244244.345.172.756984723.81717559CS
521.1147.43589743592.346.132.138201093.97114349CS
156-16.26-82.49619482519.7119.992.0056317675.3874474CS
260-7.49-68.464351005510.9428.32.0054975618.53023797CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BENFBeneficient
$ 2.40
(92.00%)
31.47M
GREEGreenidge Generation Holdings Inc
$ 3.94
(59.51%)
9.22M
IBGInnovation Beverage Group Limited
$ 1.70
(57.57%)
2.21M
RBBRBB Bancorp
$ 35.01
(41.00%)
314
GANXGain Therapeutics Inc
$ 2.40
(37.54%)
337
TFFPTFF Pharmaceuticals Inc
$ 0.473
(-70.44%)
315.05k
TSSITSS Inc
$ 8.20
(-31.55%)
46.43k
PGCPeapack Gladstone Financial Corporation
$ 25.01
(-31.39%)
25
HSTMHealthStream Inc
$ 22.00
(-31.31%)
100
HTBIHomeTrust Bancshares Inc
$ 26.20
(-29.85%)
104
BENFBeneficient
$ 2.40
(92.00%)
31.47M
ELABElevai Labs Inc
$ 0.0239
(-8.78%)
30.27M
GREEGreenidge Generation Holdings Inc
$ 3.94
(59.51%)
9.22M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
$ 17.61
(0.00%)
7.04M
QUBTQuantum Computing Inc
$ 3.21
(-27.05%)
5.12M

Discussion

View Full Feed
weedtrader420 weedtrader420 3 minutes ago
🐷WEEEEEEEEEEEEEEEEEEEEEEEEEEEE
BTCUSD
tw0122 tw0122 3 minutes ago
Resistance .57 .69 and 1.41
STI
SilkRoad SilkRoad 4 minutes ago
If it is a joint web conference that will be exciting.
KBLB
madet140 madet140 4 minutes ago
What are Telstra Bigpond Webmail's email size limits?

((Call +61 1800 870 270))Telstra Bigpond Webmail is an email service provided by Telstra, one of Australia's largest telecommunications and media companies. Bigpond, the internet service division of Telstra, offers various digital
tw0122 tw0122 5 minutes ago
60% of cash reserves going to Bitcoin .54 +'58%
STI
WeTheMarket WeTheMarket 7 minutes ago
Repost from the FCEL board, courtesy of JohnnyHydrogen.
I believe he was mentioned as a probable and very positive prospect for the entire hydrogen industry during the recent Plug Power symposium.

Burgum is The Man

https://www.eenews.net/articles/trump-picking-bu
FCEL
SilkRoad SilkRoad 7 minutes ago
I think we all have had a case of that at times over the years. Some cases have been very mild, some more severe than others, and some appear to be immune to the disease. The only cure for it is metric tons of silk. Metric tons of silk will wipe the disease off the face of the Earth.
KBLB
madet140 madet140 8 minutes ago
How do I set up Telstra Bigpond Webmail on Outlook?

((Call +61 1800 870 270))Telstra Bigpond Webmail is an email service provided by Telstra, one of Australia's largest telecommunications and media companies. Bigpond, the internet service division of Telstra, offers various digital se
prototype_101 prototype_101 8 minutes ago
INSTITUTIONS 3rd_Quarter 2024 HUGE BUYING EXPLAINED!!!
9+_Million Share Increase ---> SUPER IMPORTANT to Understand the following,

Noteworthy Institutional Buying of LWLG began in late 2021, and if you look on the BAR CHART on the Fintel Intuitional Ownership page you will
LWLG
StayHumble StayHumble 8 minutes ago
Yes it is!✅w0w! NO R/s+ MERGER AQUISITION ✅ohBoy Yowza!
https://x.com/CorporateUbqu/status/1765510100628726105?s=20
https://cdn.vox-cdn.com/uploads/chorus_asset/file/8687957/tenor.gif
UBQU
Iggy_Bot Iggy_Bot 8 minutes ago
Listening to all media, the axe is in for Mat Gaetz, I hope these people realize these are Trump picks,
not wise to go against him.....
FOFreddie FOFreddie 8 minutes ago
Hey DCBill,

Do you still think that there is no chance that DJT will merge FNMA and FMCC - take out overhead - move them to Cincinnati and take the cost savings to reduce MBS Fees?

Seems like a no brainer for DOGE dont you think?
DJT FMCC
dreamaker56 dreamaker56 8 minutes ago
Q3 POSTED

https://www.otcmarkets.com/otcapi/company/financial-report/416710/content

Disclosure Statement Pursuant to the Pink Basic Disclosure Guidelines

CBD of Denver Inc.
Industriestrasse 31, 8305 Dietlikon, Switzerland
+41 (0) 44 2440034
CBDD
madet140 madet140 9 minutes ago
How can I reset my Telstra Bigpond Webmail password?

((Call +61 1800 870 270))Telstra Bigpond Webmail is an email service provided by Telstra, one of Australia's largest telecommunications and media companies. Bigpond, the internet service division of Telstra, offers various digital s
EnchantedTitan62 EnchantedTitan62 9 minutes ago
If my memory serves me right ...
AFFU
SHEEPWOLF SHEEPWOLF 10 minutes ago
$ILLR +116% in the last couple weeks.
Green 10 of 14 sessions, strong uptrend and seriously bright future. Most undervalued publicly traded social media company.
https://investorshub.advfn.com/uimage/uploads/2024/11/15/vqpxhimageedit_9_8871305628.jpg
ILLR
WeTheMarket WeTheMarket 10 minutes ago
Hog, here is the article UK was referring to.

Bloom Energy Announces Gigawatt Fuel Cell Procurement Agreement with AEP to Power AI Data Centers
November 14, 2024
https://newsroom.bloomenergy.com/news/bloom-energy-announces-gigawatt-fuel-cell-procurement-agreement-with-a
AEP
TheFinalCD TheFinalCD 10 minutes ago
BIG Institutions are buying and adding https://x.com/ChuckHodl/status/1857122475244486756
GME
EnchantedTitan62 EnchantedTitan62 11 minutes ago
I have noticed they have shared space with U Mobile occasionally.
AFFU
SHEEPWOLF SHEEPWOLF 11 minutes ago
$ILLR +116% in the last couple weeks.
Green 10 of 14 sessions, strong uptrend and seriously bright future. Most undervalued publicly traded social media company.
https://investorshub.advfn.com/uimage/uploads/2024/11/15/vqpxhimageedit_9_8871305628.jpg
ILLR
StayHumble StayHumble 12 minutes ago
wow✅ $50 POSSIBLE with these✅HISTORIC EXPERT BUYS✅https://ih.advfn.com/stock-market/USOTC/gncc-capital-ce-GNCP/historical✅
GNCP
JakBqk JakBqk 12 minutes ago
I've made profits off more "evil" stocks than this one 😉
👍👍
Y'all make fun of Henry saying GB but then you post bible scripture 😂😂😂😂😂
YO! Wherredeydodatat?
PHIL
StayHumble StayHumble 13 minutes ago
Power2 the P1ayers✅24/7 interest here✅ ✅ ✅ ✅
GME
TMaga TMaga 13 minutes ago
Name the companies paying HCMC for those rights.
Billion share buyback? Show me the money.
Let's see what the NEW COURT says. Will take some time. If Cozen was able to fill all the holes PM poked into their patent, then maybe something positive will happen.
HCMC
$PennyMover $PennyMover 13 minutes ago
We still don't have a website yet (after 4 attempts, financials will be late. What else is not new
GRLF

Your Recent History

NASDAQ
STRO
Sutro Biopharma
NYSE
DSM
BNY Mellon Strategic Mun...
TSX
TWM
Tidewater Midstream and ...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved